Sign In
Buy ELAN
$23.89
-0.330 (-1.36%)
At Close: Jun 22, 2026
Elanco price target raised to $11 from $9.50 at Leerink
01:43pm, Wednesday, 07'th May 2025
Leerink analyst Daniel Clark raised the firm's price target on Elanco to $11 from $9.50 and keeps a Market Perform rating on the shares. The firm says the company's quarter was solid, and its exposure
Elanco Animal Health Incorporated (ELAN) Q1 2025 Earnings Call Transcript
12:52pm, Wednesday, 07'th May 2025
Elanco Animal Health Incorporated (NYSE:ELAN ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Tiffany Kanaga - Head of Investor Relations Jeffrey Simmons - President and
Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide
11:03am, Wednesday, 07'th May 2025
Elanco Animal Health Incorporated ELAN reported first-quarter 2025 adjusted earnings per share of 37 cents. That's up 9% year over year.
Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics
10:35am, Wednesday, 07'th May 2025
While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metr
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates
08:35am, Wednesday, 07'th May 2025
Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.34 per share a ye
Elanco Animal Health Reports First Quarter 2025 Results
06:27am, Wednesday, 07'th May 2025
Accelerating Debt Paydown in 2025 First Quarter 2025 Financial Results: Revenue of $1,193 million, a decline of 1% year-over-year; 4% organic constant currency growth Reported Net Income of $67 millio
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal
04:40pm, Monday, 05'th May 2025
Elanco Animal Health Incorporated ELAN on Monday announced the sale of certain future tiered royalties and commercial milestones associated with Xdemvy (lotilaner ophthalmic solution) 0.25% for the hu
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown
06:27am, Monday, 05'th May 2025
GREENFIELD, Ind. , May 5, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the sale of certain future tiered royalties and commercial milestones associated with XDEM
NEW YORK CITY, NY / ACCESS Newswire / May 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the
NEW YORK CITY, NY / ACCESS Newswire / May 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q1 Earnings Expected to Decline
11:06am, Wednesday, 30'th Apr 2025
Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Elanco Animal Health Incorporat
NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "t
NEW YORK CITY, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "t
Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco
01:16pm, Wednesday, 23'rd Apr 2025
Sarat Sethi, Managing Partner at DCLA, joins CNBC's "Halftime Report" to detail his latest trades.
